Tata Elxsi shares slide 6% after weak Q1 outcomes. Why Motilal Oswal sees 16% draw back from present ranges?
The corporate’s revenue earlier than tax (PBT) stood at Rs. 232.5 crore in the course of the quarter, up 18.4% from a yr in the past, with a PBT margin of 21.9%.
Working efficiency additionally remained robust, with EBITDA rising 15.7% year-on-year to Rs. 216 crore. The corporate reported an EBITDA margin of 21.2%, whereas its web revenue margin got here in at 16.1% for the quarter.
What are analysts saying?
Motilal Oswal has maintained its Promote ranking on Tata Elxsi with a goal value of Rs. 3,100, implying a draw back of round 16% from present ranges.The brokerage stated the corporate’s June quarter efficiency does little to change its broader progress outlook. Income grew 1.3% quarter-on-quarter in fixed forex, broadly in step with expectations, however the progress was largely pushed by the Media & Communications phase. The bigger Transportation enterprise, which contributes round 55% of income, together with Healthcare, continued to stay weak.
Motilal Oswal believes a significant restoration in Tata Elxsi’s progress will depend upon an enchancment within the Transportation phase, the place consumer spending, significantly throughout Europe, stays cautious.
The brokerage additionally highlighted that margins had been considerably under expectations. Tata Elxsi’s EBIT margin contracted to 19%, lacking its estimate of 21.5%.
Alternative Institutional Equities has downgraded Tata Elxsi to Promote and reduce its goal value to Rs. 3,150 from Rs. 3,650, after decreasing its FY27 and FY28 earnings estimates by 2.7% and 6.0%, respectively.
The brokerage stated Tata Elxsi’s Q1FY27 efficiency was weaker than anticipated, with margins damage by increased challenge prices and continued strategic investments regardless of wholesome progress within the Transportation and Media & Communications segments.
Whereas the corporate’s administration continues to focus on excessive single-digit income progress in FY27, backed by a wholesome large-deal pipeline and an anticipated restoration within the Healthcare enterprise, Alternative Institutional Equities stays extra cautious. It cited continued weak point within the European automotive market and delays in healthcare order conversions as key dangers.
The brokerage additionally famous that Tata Elxsi is accelerating investments in AI capabilities, platforms and expertise to strengthen its domain-plus-AI providing. Whereas these investments are anticipated to enhance the corporate’s long-term progress prospects and competitiveness, they’re more likely to maintain margins below strain within the close to time period.
Tata Elxsi Q1 administration commentary
Tata Elxsi stated its Healthcare and Life Sciences enterprise grew 1.7% quarter-on-quarter regardless of a subdued demand atmosphere within the healthcare {industry}. The corporate stated it’s investing in an AI-first, design-led and regulatory-aware engineering strategy for the phase, whereas partnering with main international AI corporations. In the course of the quarter, it launched ViTEL, a GenAI-powered materials intelligence platform, and AnaTEL, an AI-native software program growth platform for the medtech and healthcare {industry}.
The corporate stated it stays nicely positioned to handle clients’ strategic priorities throughout its focus verticals, together with related, clever and software-defined merchandise, digital transformation, AI-led efficiencies, buyer expertise and engineering modernisation.
Tata Elxsi added that it stays centered on delivering sustainable progress by deepening relationships with key clients, pursuing long-term strategic offers, including marquee shoppers and sustaining its industry-leading margins.
(Disclaimer: Suggestions, ideas, views and opinions given by the specialists are their very own. These don’t characterize the views of The Financial Instances)
